Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 2240-2253, 2004. First published September 30, 2004; 10.1373/clinchem.2004.039875
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.039875v1
50/12/2240    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (48)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francesconi, K. A.
Right arrow Articles by Pannier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francesconi, K. A.
Right arrow Articles by Pannier, F.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Nutrition
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2004;50:2240-2253.)
© 2004 American Association for Clinical Chemistry, Inc.

Review

Selenium Metabolites in Urine: A Critical Overview of Past Work and Current Status

Kevin A. Francesconi1,a and Florence Pannier2

1 Institute of Chemistry-Analytical Chemistry, Karl-Franzens University Graz, Graz, Austria.
2 University of Pau and Pays de L’Adour, Unité de Recherche 5034 Centre National de la Recherche Scientifique, Laboratoire de Chimie Analytique Bio-Inorganique et Environment, Pau, France.

aAddress correspondence to this author at: Institute of Chemistry-Analytical Chemistry, Karl-Franzens University Graz, 8010 Graz, Austria. Fax 43-316-3809845; e-mail kevin.francesconi{at}uni-graz.at.

Background: Selenium is an essential trace element that also elicits toxic effects at modest intakes. Investigations of selenium metabolites in urine can help our understanding of the transformations taking place in the body that produce these beneficial and detrimental effects. There is, however, considerable discord in the scientific literature regarding the selenium metabolites thought to play important roles in these biotransformation processes.

Approach: We critically assessed the published reports on selenium urinary metabolites, from the first report in 1969 to the present, in terms of the rigor of the data on which structures have been proposed.

Content: We present and discuss data from ~60 publications reporting a total of 16 identified selenium metabolites in urine of humans or rats, a good model for human selenium metabolism. We assessed the analytical methods used and the validity of the ensuing structural assignments.

Summary: Many of the studies of selenium metabolites in urine appear to have assigned incorrect structures to the compounds. The long-held view that trimethylselenonium ion is a major human urinary metabolite appears unjustified. On the other hand, recent work describing selenosugars as major urinary metabolites looks sound and provides a firm basis for future studies.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Biol. Chem.Home page
D. Sagher, D. Brunell, N. Brot, B. L. Vallee, and H. Weissbach
Selenocompounds Can Serve as Oxidoreductants with the Methionine Sulfoxide Reductase Enzymes
J. Biol. Chem., October 20, 2006; 281(42): 31184 - 31187.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.